Abstract
1. Propranolol, in doses of 25-100 μg/kg, blocks contractions of the nictitating membrane to nerve stimulation but not to injected noradrenaline.
2. This adrenergic neurone blocking action of propranolol is antagonized by amphetamine.
3. It is also reversed by raising the dose of propranolol to amounts exceeding 0·5 mg/kg.
4. Still larger amounts potentiate the responses of the nictitating membrane to both submaximal stimulation of the cervical sympathetic nerve and to injected noradrenaline.
5. The (+) isomer of propranolol produced adrenergic nerve blockade and some degree of hypotension without blocking cardiac β-adrenoceptors.
6. The relevance of adrenergic neurone blockade to the hypotensive effect of propranolol is discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrett A. M., Nunn B. Adrenergic neuron blocking properties of (plus or minus)-propranolol and (plus)-propranolol. J Pharm Pharmacol. 1970 Nov;22(11):806–810. doi: 10.1111/j.2042-7158.1970.tb08443.x. [DOI] [PubMed] [Google Scholar]
- CHANG C. C., COSTA E., BRODIE B. B. INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther. 1965 Mar;147:303–312. [PubMed] [Google Scholar]
- Day M. D., Owen D. A., Warren P. R. An adrenergic neuron blocking action of propranolol in isolated tissues. J Pharm Pharmacol. 1968 Dec;20(Suppl):130S+–130S+. doi: 10.1111/j.2042-7158.1968.tb09874.x. [DOI] [PubMed] [Google Scholar]
- Dorph S., Binder C. Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension. Acta Med Scand. 1969 May;185(5):443–448. doi: 10.1111/j.0954-6820.1969.tb07362.x. [DOI] [PubMed] [Google Scholar]
- Farmer J. B., Levy G. P. A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals. Br J Pharmacol. 1968 Sep;34(1):116–126. doi: 10.1111/j.1476-5381.1968.tb07955.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foo J. W., Jowett A., Stafford A. The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart. Br J Pharmacol. 1968 Sep;34(1):141–147. doi: 10.1111/j.1476-5381.1968.tb07957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frohlich E. D., Tarazi R. C., Dustan H. P., Page I. H. The paradox of beta-adrenergic blockade in hypertension. Circulation. 1968 Mar;37(3):417–423. doi: 10.1161/01.cir.37.3.417. [DOI] [PubMed] [Google Scholar]
- Mylecharane E. J., Raper C. Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig. Br J Pharmacol. 1970 May;39(1):128–138. doi: 10.1111/j.1476-5381.1970.tb09562.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raper C., Wale J. Sympathetic involvement in vagal escape and the effects of beta-receptor blocking drugs. Eur J Pharmacol. 1969 Oct;8(1):47–57. doi: 10.1016/0014-2999(69)90128-9. [DOI] [PubMed] [Google Scholar]
- Zacharias F. J., Cowen K. J. Controlled trial of propranolol in hypertension. Br Med J. 1970 Feb 21;1(5694):471–474. doi: 10.1136/bmj.1.5694.471. [DOI] [PMC free article] [PubMed] [Google Scholar]